Procyon Advisors LLC Boosts Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Procyon Advisors LLC lifted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 7.8% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 6,744 shares of the medical equipment provider’s stock after purchasing an additional 487 shares during the period. Procyon Advisors LLC’s holdings in Intuitive Surgical were worth $3,520,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds have also recently modified their holdings of ISRG. State Street Corp increased its stake in Intuitive Surgical by 1.4% during the 3rd quarter. State Street Corp now owns 15,050,121 shares of the medical equipment provider’s stock worth $7,393,673,000 after buying an additional 210,363 shares in the last quarter. FMR LLC boosted its stake in shares of Intuitive Surgical by 8.3% in the third quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock worth $5,389,765,000 after acquiring an additional 838,793 shares during the last quarter. Geode Capital Management LLC increased its position in shares of Intuitive Surgical by 1.9% during the third quarter. Geode Capital Management LLC now owns 7,512,925 shares of the medical equipment provider’s stock worth $3,677,194,000 after purchasing an additional 143,440 shares in the last quarter. Fisher Asset Management LLC raised its stake in Intuitive Surgical by 1.8% in the 3rd quarter. Fisher Asset Management LLC now owns 4,782,381 shares of the medical equipment provider’s stock valued at $2,349,441,000 after purchasing an additional 86,208 shares during the last quarter. Finally, Baillie Gifford & Co. lifted its holdings in Intuitive Surgical by 0.6% in the 3rd quarter. Baillie Gifford & Co. now owns 3,848,547 shares of the medical equipment provider’s stock valued at $1,890,676,000 after purchasing an additional 24,183 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Stock Performance

Intuitive Surgical stock opened at $584.08 on Friday. The company’s 50 day simple moving average is $538.34 and its 200-day simple moving average is $497.08. Intuitive Surgical, Inc. has a 1 year low of $355.17 and a 1 year high of $585.50. The company has a market capitalization of $208.04 billion, a price-to-earnings ratio of 93.90, a price-to-earnings-growth ratio of 4.66 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.24 by $0.32. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. The company had revenue of $2.04 billion for the quarter, compared to analyst estimates of $2.01 billion. Equities analysts expect that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current year.

Insiders Place Their Bets

In other Intuitive Surgical news, EVP Brian Edward Miller sold 2,553 shares of the business’s stock in a transaction on Tuesday, October 22nd. The shares were sold at an average price of $515.00, for a total value of $1,314,795.00. Following the completion of the transaction, the executive vice president now owns 7,066 shares in the company, valued at $3,638,990. The trade was a 26.54 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, CFO Jamie Samath sold 270 shares of the stock in a transaction on Tuesday, December 10th. The shares were sold at an average price of $540.15, for a total value of $145,840.50. Following the completion of the sale, the chief financial officer now owns 8,757 shares in the company, valued at approximately $4,730,093.55. The trade was a 2.99 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 48,190 shares of company stock worth $25,012,927 over the last three months. Company insiders own 0.80% of the company’s stock.

Wall Street Analyst Weigh In

ISRG has been the subject of a number of recent research reports. Morgan Stanley upgraded shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and increased their target price for the company from $522.00 to $650.00 in a research report on Monday, December 2nd. BTIG Research increased their price objective on shares of Intuitive Surgical from $535.00 to $561.00 and gave the company a “buy” rating in a report on Tuesday, November 26th. Mizuho boosted their target price on Intuitive Surgical from $440.00 to $500.00 in a report on Thursday, October 17th. Leerink Partners increased their price target on Intuitive Surgical from $489.00 to $502.00 in a report on Thursday, October 17th. Finally, Wells Fargo & Company boosted their price objective on Intuitive Surgical from $549.00 to $630.00 and gave the stock an “overweight” rating in a research note on Wednesday, December 11th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $554.17.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.